Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Diabetes

Free Subscription Articles published in Hypertension Retrieve available abstracts of 31 articles: HTML format

Single Articles

April 2024
1. CROWLEY SD, Navar LG, Prieto MC, Gurley SB, et al
   Kidney Renin-Angiotensin System: Lost in a RAS Cascade.
   Hypertension. 2024;81:682-686.
   PubMed     Abstract available
   
   
   
2. DE LEMOS JA, Linetzky B, le Roux CW, Laffin LJ, et al
   Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With Body Mass Index >/=27 kg/m(2): SURMOUNT-1 Ambulatory Blood Pressure Monitoring Substudy.
   Hypertension. 2024;81:e41-e43.
   PubMed    
   
   
   March 2024
3. LIU X, Nianogo R, Janzen C, Fei Z, et al
   Association Between Gestational Diabetes Mellitus and Hypertension: A Systematic Review and Meta-Analysis of Cohort Studies With a Quantitative Bias Analysis of Uncontrolled Confounding.
   Hypertension. 2024 Mar 19. doi: 10.1161/HYPERTENSIONAHA.123.22418.
   PubMed     Abstract available
   
   
   
4. ACHARYA S, Neupane G, Seals A, Kc M, et al
   Self-Measured Blood Pressure-Guided Pharmacotherapy: A Systematic Review and Meta-Analysis of United States-Based Telemedicine Trials.
   Hypertension. 2024;81:648-657.
   PubMed     Abstract available
   
   
   February 2024
5. MATTSSON K, Pihlsgard M, Enhorning S, Timpka S, et al
   Incident Cardiovascular Disease in Women With Type 1 or Type 2 Diabetes Following a Hypertensive Disorder of Pregnancy.
   Hypertension. 2024 Feb 22. doi: 10.1161/HYPERTENSIONAHA.123.22081.
   PubMed     Abstract available
   
   
   November 2023
6. KIDAWARA Y, Kadoya M, Igeta M, Morimoto A, et al
   Nocturnal Hypertension and Left Ventricular Diastolic Dysfunction in Patients With Diabetes With the Absence of Heart Failure: Prospective Cohort HSCAA Study.
   Hypertension. 2023 Nov 22. doi: 10.1161/HYPERTENSIONAHA.123.21304.
   PubMed     Abstract available
   
   
   
7. PARAMSOTHY A, Hegvik TA, Engeland A, Bjorge T, et al
   Fetal Exposure to Preeclampsia and Later Risk of Cardiometabolic Disorders: A Population-Based Cohort Study.
   Hypertension. 2023;80:e158-e166.
   PubMed     Abstract available
   
   
   October 2023
8. ATAWIA RT, Batori RK, Jordan CR, Kennard S, et al
   Type 1 Diabetes Impairs Endothelium-Dependent Relaxation Via Increasing Endothelial Cell Glycolysis Through Advanced Glycation End Products, PFKFB3, and Nox1-Mediated Mechanisms.
   Hypertension. 2023;80:2059-2071.
   PubMed     Abstract available
   
   
   September 2023
9. ADDISON ML, Ranasinghe P, Webb DJ
   Novel Pharmacological Approaches in the Treatment of Hypertension: A Focus on RNA-Based Therapeutics.
   Hypertension. 2023 Sep 14. doi: 10.1161/HYPERTENSIONAHA.122.19430.
   PubMed     Abstract available
   
   
   
10. SANTULLI G, Varzideh F, Forzano I, Wilson S, et al
    Functional and Clinical Importance of SGLT2-inhibitors in Frailty: From the Kidney to the Heart.
    Hypertension. 2023;80:1800-1809.
    PubMed     Abstract available
    
    
    August 2023
11. CARDOSO CRL, Leite NC, Salles GF
    Prognostic Impact of On-Treatment Cumulative Ambulatory Blood Pressures for Adverse Macro- and Microvascular Outcomes in Individuals With Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort.
    Hypertension. 2023 Aug 7. doi: 10.1161/HYPERTENSIONAHA.123.21514.
    PubMed     Abstract available
    
    
    
12. VERDECCHIA P, Reboldi G, Angeli F
    It Is Time to Reconsider the Blood Pressure Targets in Patients With Type 2 Diabetes?
    Hypertension. 2023;80:1654-1657.
    PubMed    
    
    
    July 2023
13. LIANG XC, Savu A, Ngwezi D, Butalia S, et al
    Association Between Maternal Glucose Levels in Gestational Diabetes Screening and Subsequent Hypertension.
    Hypertension. 2023 Jul 14. doi: 10.1161/HYPERTENSIONAHA.123.21179.
    PubMed     Abstract available
    
    
    May 2023
14. YANG Q, Zheng R, Wang S, Zhu J, et al
    Systolic Blood Pressure Control Targets to Prevent Major Cardiovascular Events and Mortality in Patients With Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.
    Hypertension. 2023 May 31. doi: 10.1161/HYPERTENSIONAHA.123.20954.
    PubMed     Abstract available
    
    
    December 2022
15. RAO S, Li Y, Nazarzadeh M, Canoy D, et al
    Systolic Blood Pressure and Cardiovascular Risk in Patients With Diabetes: A Prospective Cohort Study.
    Hypertension. 2022 Dec 30. doi: 10.1161/HYPERTENSIONAHA.122.20489.
    PubMed     Abstract available
    
    
    
16. SCHAFER M, Browne LP, Truong U, Bjornstad P, et al
    Bromocriptine Improves Central Aortic Stiffness in Adolescents With Type 1 Diabetes: Arterial Health Results From the BCQR-T1D Study.
    Hypertension. 2022 Dec 6. doi: 10.1161/HYPERTENSIONAHA.122.19547.
    PubMed     Abstract available
    
    
    November 2022
17. RIVERA AS, Rusie L, Plank M, Siddique J, et al
    Association of Cumulative Viral Load With the Incidence of Hypertension and Diabetes in People With HIV.
    Hypertension. 2022;79:e135-e142.
    PubMed     Abstract available
    
    
    October 2022
18. RUILOPE LM, Agarwal R, Anker SD, Filippatos G, et al
    Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes.
    Hypertension. 2022 Oct 12. doi: 10.1161/HYPERTENSIONAHA.122.19744.
    PubMed     Abstract available
    
    
    August 2022
19. SCHULTZ MG, Otahal P, Kovacevic AM, Roberts-Thomson P, et al
    Type-2 Diabetes and the Clinical Importance of Exaggerated Exercise Blood Pressure.
    Hypertension. 2022 Aug 8:101161HYPERTENSIONAHA12219420.
    PubMed     Abstract available
    
    
    June 2022
20. MONE P, Varzideh F, Jankauskas SS, Pansini A, et al
    SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic Patients.
    Hypertension. 2022 Jun 15:101161HYPERTENSIONAHA12219586.
    PubMed     Abstract available
    
    
    
21. KIM HK, Ishizawa R, Fukazawa A, Wang Z, et al
    Dapagliflozin Attenuates Sympathetic and Pressor Responses to Stress in Young Prehypertensive Spontaneously Hypertensive Rats.
    Hypertension. 2022 Jun 2:101161HYPERTENSIONAHA12219177.
    PubMed     Abstract available
    
    
    May 2022
22. HUI BAE E, Yeob Lim S, Kim B, Ryom Oh T, et al
    Effects of Blood Pressure According to Age on End-Stage Renal Disease Development in Patients With Patients With Diabetes: A Nationwide Population-Based Cohort Study.
    Hypertension. 2022 May 24:101161HYPERTENSIONAHA12118881.
    PubMed     Abstract available
    
    
    
23. TIAN X, Zuo Y, Chen S, Zhang Y, et al
    Hypertension, Arterial Stiffness, and Diabetes: a Prospective Cohort Study.
    Hypertension. 2022 May 16:101161HYPERTENSIONAHA12219256.
    PubMed     Abstract available
    
    
    
24. CHEN W, Han Y, Wang Y, Chen X, et al
    Glucose Metabolic Disorders Enhance Vascular Dysfunction Triggered by Particulate Air Pollution: a Panel Study.
    Hypertension. 2022;79:1079-1090.
    PubMed     Abstract available
    
    
    
25. VASAN RS, Pan S, Xanthakis V, Beiser A, et al
    Arterial Stiffness and Long-Term Risk of Health Outcomes: The Framingham Heart Study.
    Hypertension. 2022;79:1045-1056.
    PubMed     Abstract available
    
    
    April 2022
26. MUZUROVIC E, Peng CC, Belanger MJ, Sanoudou D, et al
    Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors.
    Hypertension. 2022 Apr 25:101161HYPERTENSIONAHA12217982.
    PubMed     Abstract available
    
    
    
27. PARCHA V, Pampana A, Bress AP, Irvin MR, et al
    Association of Polygenic Risk Score With Blood Pressure and Adverse Cardiovascular Outcomes in Individuals With Type II Diabetes: Insights From the ACCORD Trial.
    Hypertension. 2022 Apr 4:HYPERTENSIONAHA12218976.
    PubMed    
    
    
    
28. WILSON JR, Garner EM, Mashayekhi M, Hubers SA, et al
    DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment.
    Hypertension. 2022;79:827-835.
    PubMed     Abstract available
    
    
    October 2021
29. JIA G, Sowers JR
    Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease.
    Hypertension. 2021 Oct 4:HYPERTENSIONAHA12117981.
    PubMed     Abstract available
    
    
    July 2021
30. HIROHAMA D, Nishimoto M, Ayuzawa N, Kawarazaki W, et al
    Activation of Rac1-Mineralocorticoid Receptor Pathway Contributes to Renal Injury in Salt-Loaded db/db Mice.
    Hypertension. 2021;78:82-93.
    PubMed     Abstract available
    
    
    June 2021
31. MORIKAWA N, Bancks MP, Yano Y, Kuwabara M, et al
    Serum Urate Trajectory in Young Adulthood and Incident Cardiovascular Disease Events by Middle Age: CARDIA Study.
    Hypertension. 2021 Jun 7:HYPERTENSIONAHA12117555.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.